ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced that seven abstracts have been accepted as poster presentations at the Muscular Dystrophy Association (MDA) Clinical and ...

As president of Advocate Good Samaritan Hospital in Downers Grove, Eric Rhodes understands the fundamentals of healthy living ...

An expert discusses the therapeutic options included in the NCCN guidelines for metastatic castration-resistant prostate ...

Presentation to highlight Autonomix’s catheter-based technology and key findings from lead-in patients in ongoing human clinical trial in ...

Dr. Nicholas Theodore to highlight NOCISCAN capabilities combining MR Spectroscopy and augmented intelligence (AI) NOCISCAN is an innovative ...

In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: Thursday ...

Annovis Bio, Inc. (NYSE: ANVS) will hold a live webcast aimed at providing patients, caregivers, and families with updates on ...

Heading into 2025, the chief item on argenx’s agenda is the FDA’s April 10 target action date to decide on the approval of a ...

Shoppers at the Rockbourne Fair put their money where their hearts are, smashing records and raising an impressive £62,081 ...

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Content oversight and quality assurance provided by Studio 1847 Health care-associated infections pose a persistent and tremendous threat to patient safety. According to the Centers for Disease ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new ...